[ globenewswire.com/news-release/2018/03/16/1441421/0/en/Hydropothecary-partners-with-Segra-to-scale-up-production-in-preparation-for-cannabis-legalization.html ]
GNW: Hydropothecary partners with Segra to scale-up production in preparation for cannabis legalization (2018-Mar-16)
« Segra’s expertise and unique tissue culture technique will allow Hydropothecary to increase its yield of healthy, top-quality plants to serve the growing medical and recreational cannabis markets. … This process replaces traditional cloning from mother plants with rapid, sterile production of robust and healthy plantlets. It generates exact copies of the original plant without the risk of pathogens, fungi, and other issues that can plague other industrial-scale production processes. … Segra is a plant biotechnology company that specializes in industrial-scale cannabis plant micropropagation. The company is developing industrial-scale cannabis micropropagation laboratories to produce healthy, robust plantlets for licensed cannabis producers globally. »
…
M’well, correct me if i’m wrong but, euh… Ain’t “tissue culture”/“micropropagation” part of a genetic engineering process where some new “transgene” gets integrated into a single “transformed cell” for regeneration as a complete individual plant that’s capable of passing its permanent transgenic genome to new mutant generations?! Paving the way to GMO Bio-Markers, for example…
Further reading on related matters:
http://naturalsociety.com/united-nations-doctor-outlines-5-key-gmo-dangers-in-recent-talk/
NS: United Nations Doctor Outlines 5 Key GMO Dangers in Recent Talk (2015-Oct-13)
- GMOs are Not ‘Substantially Equivalent’ to Non-GMO Foods
- GMO Safety Testing is Fragile
- GMO Crops Likely Spark Gut Ailments
- ‘Feeding Studies’ are Not ‘Required’ by Biotech
- Biotech Funds its own Studies
